Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:5
  • preuzimanja u poslednjih 30 dana:3
članak: 3 od 3  
Back povratak na rezultate
Vojnosanitetski pregled
2010, vol. 67, br. 1, str. 55-58
jezik rada: srpski
vrsta rada: originalan članak
objavljeno: 27/04/2010
doi: 10.2298/VSP1001055M
Uticaj hirurškog lečenja benigne hiperplazije prostate na simptome mokrenja i punjenja mokraćne bešike
aKlinički centar Republike Srpske, Klinika za urologiju, Banja Luka, Republika Srpska, BiH
bBolnica Sveti Apostol Luka, Odeljenje urologije, Doboj, Bosna i Hercegovina

e-adresa: smilicevic@blic.net

Sažetak

Benigna hiperplazija prostate (BHP) jedna je od najčešćih bolesti starijih muškaraca. Cilj studije bio je procena učinka hirurškog lečenja benigne hiperlazije prostate na simptome mokrenja i simptome punjenja mokraćne bešike. Kvantifikacija simptoma izvršena je pomoću Internacionalnog prostata simptoma skora (IPSS). Metode. U studiju je bilo uključeno 80 bolesnika sa BHP, od kojih je 40 operativno lečeno metodom otvorene prostatektomije (grupa A), a preostalih 40 metodom transuretralne resekcije prostate (grupa B). Svi bolesnici bili su ispod 80 godina starosti (prosečna starost u grupi A bila je 70,23 godina sa intervalom varijacije 21 godinu, a u grupi B 69,37 godina sa intervalom varijacije 22 godine) i sa vrednošću IPSS > 19 bodova, količinom rezidualnog urina većom od 150 mL, težinom tkiva prostate preko 30 grama za metodu transuretralne resekcije prostate, a preko 80 grama za metodu otvorene prostatektomije. Svim bolesnicima preoperativno, u dva navrata, određivana je vrednost IPSS, a potom i u postoperativnom periodu u vremenskim intervalima od 4 i 12 nedelja. Rezultati. Aritmetička sredina IPSS preoperativno iznosila je kod grupe A 32,05 bodova, a kod grupe B 31,75 bodova. Prilikom postoperativnih kontrola u vremenskim intervalima od 4 i 12 nedelja aritmetičke sredine IPSS u grupi A iznosile su 5,4 i 1,85 bodova, a u grupi B 11,425 i 9,025 bodova. Hirurško lečenje BHP imalo je izrazitiji učinak na simptome mokrenja nego na simptome punjenja. Zaključak. Nakon sprovedenih operativnih zahvata dolazi do značajne redukcije simptoma donjeg dela urinarnog trakta pri čemu hirurško lečenje ima veći efekat na simptome mokrenja nego na simptome punjenja mokraćne bešike.

Ključne reči

Reference

Abrams, P., Cardozo, L., Fall, M., Griffiths, D., Rosier, P., Ulmsten, U., i dr. (2003) The standardization of terminology in lower urinara tract function: Report from the standardization sub-committee of the International Continence Society. Urology, 61(1): 37
Berges, R.R., Pientka, L. (1999) Management of the BPH syndrome in Germany: Who is treated and how?. European urology, 36 Suppl 3: 21-7
Bosch, J.L., Hop, W.C., Kirkels, W.J., Schroder, F.H. (1995) The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: Prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. British journal of urology, 75(5): 622-30
Bruskewitz, R. (1999) Management of symptomatic BPH in the US: Who is treated and how?. European urology, 36 Suppl 3: 7-13
Chute, C.G., Panser, L.A., Girman, C.J., Oesterling, J.E., Guess, H.A., Jacobsen, S.J., Lieber, M.M. (1993) The prevalence of prostatism: A population-based survey of urinary symptoms. Journal of urology, 150(1): 85-9
Emberton, M. (2003) The hallmarks of BPH progession and risk factors. European Urology Supplements, 2(8): 2
Garraway, W.M., Russell, E.B., Lee, R.J., Collins, G.N., McKelvie, G.B., Hehir, M., Rogers, A.C., Simpson, R.J. (1993) Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. British journal of general practice, 43(373): 318-21
Hakenberg, O.W., Pinnock, C.B., Marshall, V.R. (1999) The follow-up of patients with unfavourable early results of transurethral prostatectomy. BJU international, 84(7): 799-804
Hunter, D.J., Berra-Unamuno, A., Martin-Gordo, A. (1996) Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old or older. Journal of urology, 155(6): 1965-70
Ichiyanagi, O., Ishigooka, M., Hashimoto, T., Hayani, S., Suzuki, Y., Nakada, T. (1997) The American Urological Association Symptom Index: Early postoperative evaluation of irritative and obstructive symptoms due to benign prostatic hyperplasia. International urology and nephrology, 29(4): 441-7
Ignjatovic, I. (2001) Symptoms and urodynamics after unsuccessful transurethral prostatectomy. International urology and nephrology, 32(4): 655-8
Lukacs, B. (1999) Management of symptomatic BPH in France: Who is treated and how?. European urology, 36 Suppl 3: 14-20
Mcnicholas, T.A. (1999) Management of symptomatic BPH in the UK: Who is treated and how?. Eur Urol, 36 Suppl 3: 33-9
Mearini, E., Marzi, M., Mearini, L., Zucchi, A., Porena, M. (1998) Open prostatectomy in benign prostatic hyperplasia: 10-year experience in Italy. European urology, 34(6): 480-5
Sagnier, P.P., MacFarlane, G., Richard, F., Botto, H., Teillac, P., Boyle, P. (1994) Results of an epidemiological survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France. Journal of urology, 151(5): 1266-70
Serretta, V., Morgia, G., Fondacaro, L., Curto, G., Lobianco, A., Pirritano, D., i dr. (1990) Members of the Sicilian-Calabrian Society of Urology: Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: A contemporary series of 1800 interventions. Urology, 60(4): 623
Shapiro, E. (1990) Embryologic development of the prostate: Insights into the etiology and treatment of benign prostatic hyperplasia. Urologic clinics of North America, 17(3): 487-93
Speakman, M.J. (1999) Who should be treated and how? Evidence-based medicine in symptomatic BPH. European urology, 36 Suppl 3: 40-51
Speakman, M.J. (2001) Initial choices and final outcomes in lower urinary tract symptoms. Eur Urol, : 40
Steg, A., Ackerman, R., Gibbson, R. (1991) Surgery in BPH. u: Cockett A.T.K. [ur.] Proceedings of the First International Cosultation on BPH, Paris: SCI, pp. 203-20
Tsukamoto, T., Kumamoto, Y., Masumori, N., Miyake, H., Rhodes, T., Girman, C.J., Guess, H.A., Jacobsen, S.J., Lieber, M.M. (1995) Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. Journal of urology, 154(2 Pt 1): 391-5
Tubaro, A., Carter, S., Hind, A., Vicentini, C., Miano, L. (2001) A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia. Journal of urology, 166(1): 172-6
Tubaro, A., Montanari, E. (1999) Management of symptomatic BPH in Italy: Who is treated and how?. European urology, 36 Suppl 3: 28-32